{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["4,4-dimethylcurcumin", "LC-MS spectroscopy", "cellular uptake", "lung cancer", "water solubility"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34834146", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "22"}], "Language": ["eng"], "ELocationID": ["7050", "10.3390/molecules26227050"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "22", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "22"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Synthesis and Characterization of the Ethylene-Carbonate-Linked L-Valine Derivatives of 4,4-Dimethylcurcumin with Potential Anticancer Activities.", "Abstract": {"AbstractText": ["Natural phenolic products from herbal medicines and dietary plants constitute the main source of lead compounds for the development of the new drug. 4,4-Dimethylcurcumin (<b>DMCU</b>) is a synthetic curcumin derivative and exhibits anticancer activities against breast, colon, lung, and liver cancers. However, further development of <b>DMCU</b> is limited by unfavorable compound properties such as very low aqueous solubility and moderate stability. To increase its solubility, we installed either or both of the ethylene-carbonate-linked L-valine side chains to <b>DMCU</b> phenolic groups and produced targeted <b>1</b>-<b>trifluoroacetic acid</b> (<b>1-TFA</b>) and <b>2</b>-<b>trifluoroacetic acid</b> (<b>2-TFA</b>) derivatives. The terminus L-valine of ethylene-carbonate-linked side chain is known to be a L-type amino acid transporter 1 (LAT1) recognition element and therefore, these two derivatives were expected to readily enter into LAT1-expressing cancer cells. In practice, <b>1-TFA</b> or <b>2-TFA</b> were synthesized from <b>DMCU</b> in four steps with 34-48% overall yield. Based on the corresponding LC-MS analysis, water solubility of <b>DMCU</b>, <b>1-TFA</b>, and <b>2-TFA</b> at room temperature (25 \u00b1 1 \u00b0C) were 0.018, 249.7, and 375.8 mg/mL, respectively, indicating >10,000-fold higher solubility of <b>1-TFA</b> and <b>2-TFA</b> than <b>DMCU</b>. Importantly, anti-proliferative assay demonstrated that <b>2-TFA</b> is a potent anti-cancer agent against LAT1-expressing lung cancer cells NCI-H460, NCI-H358, and A549 cells due to its high intracellular uptake compared to <b>DMCU</b> and <b>1-TFA</b>. In this study, we logically designed and synthesized the targeted compounds, established the LC-MS analytical methods for evaluations of drug solubility and intracellular uptake levels, and showed improved solubility and anti-cancer activities of <b>2-TFA</b>. Our results provide a strategical direction for the future development of curcuminoid-like phenolic compounds."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Integrated Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan."}], "LastName": "Lee", "ForeName": "Der-Yen", "Initials": "DY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Chinese Herbal Medicine, China Medical University, Taichung 40402, Taiwan."}], "LastName": "Lin", "ForeName": "Hui-Yi", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, China Medical University, Taichung 40402, Taiwan."}], "LastName": "Ramasamy", "ForeName": "Manickavasakam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Chinese Herbal Medicine, China Medical University, Taichung 40402, Taiwan."}, {"Identifier": [], "Affiliation": "School of Pharmacy, China Medical University, Taichung 40402, Taiwan."}, {"Identifier": [], "Affiliation": "Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan."}], "LastName": "Kuo", "ForeName": "Sheng-Chu", "Initials": "SC"}, {"Identifier": ["0000-0002-7718-4069"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan."}, {"Identifier": [], "Affiliation": "Research Center for Cancer Biology, China Medical University, Taichung 40402, Taiwan."}], "LastName": "Lee", "ForeName": "Pei-Chih", "Initials": "PC"}, {"Identifier": ["0000-0001-7287-9278"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Chinese Herbal Medicine, China Medical University, Taichung 40402, Taiwan."}, {"Identifier": [], "Affiliation": "School of Pharmacy, China Medical University, Taichung 40402, Taiwan."}, {"Identifier": [], "Affiliation": "Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan."}], "LastName": "Hsieh", "ForeName": "Min-Tsang", "Initials": "MT"}], "GrantList": [{"GrantID": "108-2320-B-039-036", "Agency": "Ministry of Science and Technology", "Country": ""}, {"GrantID": "CMU109-S-35", "Agency": "China medical university", "Country": ""}, {"GrantID": "CMU108-YTY-03", "Agency": "China medical university", "Country": ""}, {"GrantID": "CMRC-CHM-5", "Agency": "Ministry of Education", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "A549 Cells"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["analogs & derivatives", "chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kikuchi H., Yuan B., Hu X., Okazaki M. Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents. Am. J. Cancer Res. 2019;8:1517\u20131535.", "ArticleIdList": ["PMC6726994", "31497340"]}, {"Citation": "Singh V.K., Arora D., Ansari M.I., Sharma P.K. Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications. Phytother. Res. 2019;33:3064\u20133089. doi: 10.1002/ptr.6508.", "ArticleIdList": ["10.1002/ptr.6508", "31515899"]}, {"Citation": "Luna-Guevara M.L., Luna-Guevara J.J., Hernandez-Carranza P., Ruiz-Espinosa H., Ochoa-Velasco C.E. Phenolic compounds: A good choice against chronic degenerative diseases. Stud. Nat. Prod. Chem. 2018;59:79\u2013108."}, {"Citation": "Fernandez-Panchon M.S., Villano D., Troncoso A.M., Garcia-Parrilla M.C. Antioxidant activity of phenolic compounds: From in vitro results to in vivo evidence. Crit. Rev. Food Sci. Nutr. 2008;48:649\u2013671. doi: 10.1080/10408390701761845.", "ArticleIdList": ["10.1080/10408390701761845", "18663616"]}, {"Citation": "Ashrap P., Zheng G., Wan Y., Li T., Hu W., Li W., Zhang H., Zhang Z., Hu J. Discovery of a widespread metabolic pathway within and among phenolic xenobiotics. Proc. Natl. Acad. Sci. USA. 2017;23:6062\u20136067. doi: 10.1073/pnas.1700558114.", "ArticleIdList": ["10.1073/pnas.1700558114", "PMC5468616", "28536195"]}, {"Citation": "Liu B.M., Bai C.L., Zhang J., Liu Y., Dong B.Y., Zhang Y.T., Liu D. In Vitro study on the interaction of 4,4-dimethylcurcumin with calf thymus DNA. J. Lumin. 2015;166:48\u201353. doi: 10.1016/j.jlumin.2015.04.037.", "ArticleIdList": ["10.1016/j.jlumin.2015.04.037"]}, {"Citation": "Oliveira A.S., Sousa E., Vasconcelos M.H., Pinto M. Curcumin: A natural lead for potential new drug candidates. Curr. Med. Chem. 2015;22:4196\u20134232. doi: 10.2174/0929867322666151029104611.", "ArticleIdList": ["10.2174/0929867322666151029104611", "26511469"]}, {"Citation": "Liu B., Xia M., Ji X., Xu L., Dong J. Synthesis and antiproliferative effect of novel curcumin analogues. Chem. Pharm. Bull. 2013;61:757\u2013763. doi: 10.1248/cpb.c13-00295.", "ArticleIdList": ["10.1248/cpb.c13-00295", "23666373"]}, {"Citation": "Tu Z.S., Wang Q., Sun D.D., Dai F., Zhou B. Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death. Eur. J. Med. Chem. 2017;134:72\u201385. doi: 10.1016/j.ejmech.2017.04.008.", "ArticleIdList": ["10.1016/j.ejmech.2017.04.008", "28399452"]}, {"Citation": "Yang Y., Aloysius H., Inoyama D., Chen Y., Hu L. Enzyme-mediated hydrolytic activation of prodrugs. Acta Pharm. Sin. B. 2011;1:143\u2013159. doi: 10.1016/j.apsb.2011.08.001.", "ArticleIdList": ["10.1016/j.apsb.2011.08.001"]}, {"Citation": "Hsieh M.T., Chang L.C., Hung H.Y., Lin H.Y., Shih M.H., Tsai C.H., Kuo S.C., Lee K.H. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo. Eur. J. Med. Chem. 2017;131:141\u2013151. doi: 10.1016/j.ejmech.2017.03.006.", "ArticleIdList": ["10.1016/j.ejmech.2017.03.006", "28319780"]}, {"Citation": "Chang L.C., Hsieh M.T., Yang J.S., Lu C.C., Tsai F.J., Tsao J.W., Chiu Y.J., Kuo S.C., Lee K.H. Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study. Int. J. Oncol. 2018;52:67\u201376. doi: 10.3892/ijo.2017.4204.", "ArticleIdList": ["10.3892/ijo.2017.4204", "PMC5743386", "29138806"]}, {"Citation": "Lee D.Y., Hou Y.C., Yang J.S., Lin H.Y., Chang T.Y., Lee K.H., Kuo S.C., Hsieh M.T. Synthesis, anticancer activity, and preliminary pharmacokinetic evaluation of 4,4-disubstituted curcuminoid 2,2-bis(Hydroxymethyl)propionate derivatives. Molecules. 2020;25:479. doi: 10.3390/molecules25030479.", "ArticleIdList": ["10.3390/molecules25030479", "PMC7037731", "31979200"]}, {"Citation": "Barthelemy C., Andr\u00e9 B. Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter. Sci. Rep. 2019;9:16760. doi: 10.1038/s41598-019-53065-w.", "ArticleIdList": ["10.1038/s41598-019-53065-w", "PMC6856120", "31728037"]}, {"Citation": "H\u00e4fliger P., Charles R.P. The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer. Int. J. Mol. Sci. 2019;20:2428. doi: 10.3390/ijms20102428.", "ArticleIdList": ["10.3390/ijms20102428", "PMC6566973", "31100853"]}, {"Citation": "Lieu E.L., Nguyen T., Rhyne S., Kim J. Amino acids in cancer. Exp. Mol. Med. 2020;52:15\u201330. doi: 10.1038/s12276-020-0375-3.", "ArticleIdList": ["10.1038/s12276-020-0375-3", "PMC7000687", "31980738"]}, {"Citation": "Hodson N., Brown T., Joanisse S., Aguirre N., West D.W.D., Moore D.R., Baar K., Breen L., Philp A. Characterisation of L-type amino acid transporter 1 (LAT1) expression in human skeletal muscle by immunofluorescent microscopy. Nutrients. 2017;10:23. doi: 10.3390/nu10010023.", "ArticleIdList": ["10.3390/nu10010023", "PMC5793251", "29278358"]}, {"Citation": "Takeuchi K., Ogata S., Nakanishi K., Ozeki Y., Hiroi S., Tominaga S., Aida S., Matsuo H., Sakata T., Kawai T. LAT1 expression in non-small-cell lung carcinomas: Analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases) Lung Cancer. 2010;68:58\u201365. doi: 10.1016/j.lungcan.2009.05.020.", "ArticleIdList": ["10.1016/j.lungcan.2009.05.020", "19559497"]}, {"Citation": "Kaira K., Oriuchi N., Takahashi T., Nakagawa K., Ohde Y., Okumura T., Murakami H., Shukuya T., Kenmotsu H., Naito T., et al. LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer. Am. J. Transl. Res. 2011;3:468\u2013478.", "ArticleIdList": ["PMC3204889", "22046488"]}, {"Citation": "Lopes C., Pereira C., Medeiros R. ASCT2 and LAT1 Contribution to the hallmarks of cancer: From a molecular perspective to clinical translation. Cancers. 2021;13:203. doi: 10.3390/cancers13020203.", "ArticleIdList": ["10.3390/cancers13020203", "PMC7828050", "33429909"]}, {"Citation": "Vale N., Ferreira A., Matos J., Fresco P., Gouveia M.J. Amino acids in the development of prodrugs. Molecules. 2018;23:2318. doi: 10.3390/molecules23092318.", "ArticleIdList": ["10.3390/molecules23092318", "PMC6225300", "30208629"]}, {"Citation": "Puris E., Gynther M., Auriola S., Huttunen K.M. L-Type amino acid transporter 1 as a target for drug delivery. Pharm. Res. 2020;37:88. doi: 10.1007/s11095-020-02826-8.", "ArticleIdList": ["10.1007/s11095-020-02826-8", "PMC7203094", "32377929"]}, {"Citation": "Huttunen J., Peltokangas S., Gynther M., Natunen T., Hiltunen M., Auriola S., Ruponen M., Vellonen K.S., Huttunen K.M. L-type amino acid transporter 1 (LAT1/Lat1)-utilizing prodrugs can improve the delivery of drugs into neurons, astrocytes and microglia. Sci. Rep. 2019;9:12860. doi: 10.1038/s41598-019-49009-z.", "ArticleIdList": ["10.1038/s41598-019-49009-z", "PMC6731241", "31492955"]}, {"Citation": "Tranoy-Opalinski I., Fernandes A., Thomas M., Gesson J.P., Papot S. Design of self-immolative linkers for tumour-activated prodrug therapy. Anti-Cancer Agents Med. Chem. 2008;8:618\u2013637. doi: 10.2174/187152008785133065.", "ArticleIdList": ["10.2174/187152008785133065", "18690826"]}, {"Citation": "Selwan E.M., Edinger A.L. Branched chain amino acid metabolism and cancer: The importance of keeping things in context. Transl. Cancer Res. 2017;6:S578\u2013S584. doi: 10.21037/tcr.2017.05.05.", "ArticleIdList": ["10.21037/tcr.2017.05.05", "PMC6319930", "30613481"]}, {"Citation": "Basile V., Ferrari E., Lazzari S., Belluti S., Pignedoli F., Imbriano C. Curcumin derivatives: Molecular basis of their anti-cancer activity. Biochem. Pharmacol. 2009;78:1305\u20131315. doi: 10.1016/j.bcp.2009.06.105.", "ArticleIdList": ["10.1016/j.bcp.2009.06.105", "19580791"]}, {"Citation": "Imai H., Kaira K., Oriuchi N., Shimizu K., Tominaga H., Yanagitani N., Sunaga N., Ishizuka T., Nagamori S., Promchan K., et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res. 2010;30:4819\u20134828.", "ArticleIdList": ["21187458"]}, {"Citation": "Gwinn D.M., Lee A.G., Briones-Martin-Del-Campo M., Conn C.S., Simpson D.R., Scott A.I., Le A., Cowan T.M., Ruggero D., Sweet-Cordero E.A. Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase. Cancer Cell. 2018;33:91\u2013107. doi: 10.1016/j.ccell.2017.12.003.", "ArticleIdList": ["10.1016/j.ccell.2017.12.003", "PMC5761662", "29316436"]}, {"Citation": "Fernando L.P., Kandel P.K., Yu J., McNeill J., Ackroyd P.C., Christensen K.A. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules. 2010;11:2675\u20132682. doi: 10.1021/bm1007103.", "ArticleIdList": ["10.1021/bm1007103", "PMC2962534", "20863132"]}, {"Citation": "Semmling M., Kreft O., Mu\u00f1oz Javier A., Sukhorukov G.B., K\u00e4s J., Parak W.J. A novel flow-cytometry-based assay for cellular uptake studies of polyelectrolyte microcapsules. Small. 2008;4:1763\u20131768. doi: 10.1002/smll.200800596.", "ArticleIdList": ["10.1002/smll.200800596", "18819140"]}, {"Citation": "Stockert J.C., Bl\u00e1zquez-Castro A., Ca\u00f1ete M., Horobin R.W., Villanueva A. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012;114:785\u2013796. doi: 10.1016/j.acthis.2012.01.006.", "ArticleIdList": ["10.1016/j.acthis.2012.01.006", "22341561"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "6"}, {"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2021", "Month": "11", "Day": "20"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "23"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["34834146", "PMC8624457", "10.3390/molecules26227050", "molecules26227050"]}}], "PubmedBookArticle": []}